Published in Eur J Cardiothorac Surg on January 01, 1996
The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet (2000) 2.01
The aortic root: structure, function, and surgical reconstruction. Heart (2000) 1.09
The sequence of the human genome. Science (2001) 101.55
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (1991) 11.44
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 9.73
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet (1996) 7.84
Online Mendelian Inheritance in Man (OMIM). Hum Mutat (2000) 7.54
Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet (1999) 6.90
The Marfan syndrome: diagnosis and management. N Engl J Med (1979) 6.49
Implications of the Human Genome Project for medical science. JAMA (2001) 5.68
The status of the gene map of the human chromosomes. Science (1977) 5.44
Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med (1994) 5.03
International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet (1988) 4.84
The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet (1985) 4.60
The skipping of constitutive exons in vivo induced by nonsense mutations. Science (1993) 4.41
Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med (1999) 4.17
OMIM passes the 1,000-disease-gene mark. Nat Genet (2000) 3.92
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet (2009) 3.89
Life expectancy and causes of death in the Marfan syndrome. N Engl J Med (1972) 3.78
Controversy in human genetics: founder effect in Tay-Sachs disease. Am J Hum Genet (1972) 3.72
The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev (1998) 3.71
Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med (1990) 3.63
Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet (1995) 3.42
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Genomics and medicine. Dissecting human disease in the postgenomic era. Science (2001) 2.98
Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet (1997) 2.98
A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest (1994) 2.98
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci U S A (1975) 2.88
A mutated human homologue to yeast Upf1 protein has a dominant-negative effect on the decay of nonsense-containing mRNAs in mammalian cells. Proc Natl Acad Sci U S A (1998) 2.87
A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat Biotechnol (2001) 2.82
Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A (1999) 2.80
Probable assignment of the Duffy blood group locus to chromosome 1 in man. Proc Natl Acad Sci U S A (1968) 2.74
Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Science (1973) 2.74
Allelism, non-allelism, and genetic compounds among the mucopolysaccharidoses. Lancet (1972) 2.65
Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood (2001) 2.65
Surgical treatment of aneurysms of the ascending aorta in the Marfan syndrome. Results of composite-graft repair in 50 patients. N Engl J Med (1986) 2.59
When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell (2001) 2.55
Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med (2010) 2.55
The genetics of hand malformations. Birth Defects Orig Artic Ser (1978) 2.55
The 3-M syndrome: a heritable low birthweight dwarfism. Birth Defects Orig Artic Ser (1975) 2.53
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
The molecular genetics of Marfan syndrome and related disorders. J Med Genet (2006) 2.45
Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics (1993) 2.43
Abnormal collagen metabolism in cultured cells in osteogenesis imperfecta. Proc Natl Acad Sci U S A (1975) 2.36
Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum Mol Genet (2001) 2.35
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med (1994) 2.29
DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25
Mammalian orthologues of a yeast regulator of nonsense transcript stability. Proc Natl Acad Sci U S A (1996) 2.24
Cognitive outcome after coronary artery bypass: a one-year prospective study. Ann Thorac Surg (1997) 2.23
Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res (2001) 2.22
The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med (1999) 2.21
Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics (1989) 2.17
Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA (1989) 2.12
The Stickler syndrome: evidence for close linkage to the structural gene for type II collagen. Genomics (1987) 2.11
Novel Upf2p orthologues suggest a functional link between translation initiation and nonsense surveillance complexes. Mol Cell Biol (2000) 2.07
Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet (2001) 2.07
Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end. Genomics (1993) 2.05
The genetic mucopolysaccharidoses. Medicine (Baltimore) (1965) 2.04
Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet (1995) 2.01
Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics (2011) 1.96
Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med (1999) 1.95
Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol (2007) 1.95
The association of Waardenburg syndrome and Hirschsprung megacolon. Am J Med Genet (1979) 1.94
George Otto Gey. (1899-1970). The HeLa cell and a reappraisal of its origin. Obstet Gynecol (1971) 1.93
Parental age effects on the occurrence of new mutations for the Marfan syndrome. Ann Hum Genet (1972) 1.92
Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature. Medicine (Baltimore) (1970) 1.89
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med (1989) 1.88
The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am J Cardiol (1983) 1.87
Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg (2000) 1.87
Empowering primary care health professionals in medical genetics: how soon? How fast? How far? Am J Med Genet (2001) 1.86
Aortic root replacement. Risk factor analysis of a seventeen-year experience with 270 patients. J Thorac Cardiovasc Surg (1995) 1.86
Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol (1993) 1.86
Hypochondroplasia. Am J Dis Child (1971) 1.86
Type II syndactyly. Am J Hum Genet (1968) 1.85
Family-oriented follow-up. J Chronic Dis (1969) 1.84
A nomenclature for constitutional disorders of bone. J Bone Joint Surg Am (1971) 1.84
Thrombocytopenia with absent radius (TAR). Medicine (Baltimore) (1969) 1.82
The economics of clinical genetics services. III. Cognitive genetics services are not self-supporting. Am J Hum Genet (1989) 1.82
Genetic linkage confirmed between the locus for myotonic dystrophy and the ABH-secretion and Lutheran blood group loci. Am J Hum Genet (1972) 1.82
Duty to re-contact. Genet Med (2001) 1.80
The ethnic distribution of disease in the United States. J Chronic Dis (1967) 1.79
Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet (2001) 1.75